Task: Answer the multiple-choice question.
Question: Which compound exhibits a -13.771% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) C/C(=N\Nc1ccc(Cl)c(C(=O)O)c1)c1cc2ccccc2o1
(b) CCN(CC)S(=O)(=O)c1cccc(NC(=O)COC(=O)C2=COCCO2)c1
Answer: b. CCN(CC)S(=O)(=O)c1cccc(NC(=O)COC(=O)C2=COCCO2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)S(=O)(=O)c1cccc(NC(=O)COC(=O)C2=COCCO2)c1
CCN(CC)S(=O)(=O)c1cccc(NC(=O)COC(=O)C2=COCCO2)c1
[2-[3-(diethylsulfamoyl)anilino]-2-oxoethyl]2,3-dihydro-1,4-dioxine-5-carboxylate